The Current Situation in Canadian ADHD Advocacy

For more than a decade now CADDAC has been advocating with the Ministries of Education, Health, Child and Youth, Justice and Social Services. Our policy papers have been sent to all ministries across Canada impacted by ADHD, and we have personally met with many of these ministries. When CADDAC meets with government officials to advocate…

New Research Paper Addressing Concerns about Generic ADHD Medication / Health Canada Up-dates on the Issue

Since 2010 CADDAC has shared our concerns about the direct substitution of methylphenidate ER-C, a generic medication, for OROS® methylphenidate (Concerta) with Health Canada. This was done through documentation, caregiver and patient survey results and several face to face meetings. A Canadian research paper reviewing data on this issue, was recently published in the Clinical…